Form 4: BeiGene Executive Wu Xiaobin Reports Stock Sales and Option Exercises

Wu Xiaobin, President, COO & GM China of BeiGene, Ltd., reports the acquisition and disposal of company shares and the exercise of stock options on March 5, 2025.

Summary

• On March 5, 2025, Wu Xiaobin, President, COO & GM China of BeiGene, Ltd., reported transactions involving the company's securities.
• These transactions included the acquisition of 103,883 ordinary shares, the disposal of 12,365 American Depositary Shares (ADS), and the exercise of options to purchase 91,624 and 583,349 ordinary shares.
• The reported sales of ADS were executed at weighted average prices ranging from $260.3898 to $263.
• Wu Xiaobin also indirectly participates in the RMB Shares Employee Participation Plan, holding an indeterminable portion of RMB Shares.
• These sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 13, 2024.

Sentiment

Score: 5

Explanation: This is a routine disclosure of insider trading activity. The sentiment is neutral as it simply reports transactions without indicating a positive or negative outlook for the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which is crucial for maintaining market integrity and investor confidence.

Stakeholder Impact

• The reported transactions provide transparency to shareholders regarding insider trading activity.
• The transactions may influence investor sentiment depending on the perceived reasons behind the stock sales.

Key Dates